Presentation JIM 2020 Long term antithrombotic therapy in high risk PCI: Consider low-dose rivaroxaban with SAPT Presenter: Giuseppe Tarantini February 13, 2020
Presentation JIM 2020 Long-term antithrombotic therapy in high-risk PCI patients Presenter: Alberto Menozzi February 13, 2020
Presentation JIM 2020 Optimal LDL levels in patients with ACS undergoing PCI Presenter: Giuseppe Musumeci February 13, 2020
Presentation JIM 2020 Ultra LOW LDL is the target for high risk patients Presenter: Francesco Prati February 13, 2020
Presentation JIM 2020 Optimal LDL Levels In Patients With ACS Undergoing PCI Clinical Case: PCI In ACS Patients With Multivessel Disease Presenter: Ferdinando Varbella February 13, 2020
Presentation JIM 2020 Tips And Tricks In Retrograde CTO PCI Presenter: Roberto Garbo February 13, 2020
Presentation JIM 2020 Clinical Crossroads On Optimal Antithrombotic Therapy In Patients Treated With Pci Intravenous Antiplatelet Therapy In High Risk Acs Presenter: Dominick Angiolillo February 13, 2020
Presentation JIM 2020 Intravenous antiplatelet therapy in high risk ACS:GPIIb/IIIa inhibitors are still a good option Presenter: Marco Ferlini February 13, 2020